ISSN

2231-3915 (Online)
2231-3907 (Print)


Author(s): Nikhil A. Zanke, Dr.Tushar Dhekane, Ananta B. Ghonge, Ashwini A. Zanke, Akshay Akotakar

Email(s): ashwinizanke98@gmail.com

DOI: 10.52711/2231-3915.2022.00008   

Address: Nikhil A. Zanke, Dr.Tushar Dhekane, Ananta B. Ghonge, Ashwini A. Zanke, Akshay Akotakar
Sant Gajanan Collage of BSc, Motala , Maharsatra.
PMT’S Ayurved Medical College , Shevgaon, Ahmednagar.
Pankaj Laddhad Collage of Pharmacy, Buldhana-443001, Maharsatra.
*Corresponding Author

Published In:   Volume - 12,      Issue - 2,     Year - 2022


ABSTRACT:
(UC), a subcategory of inflammatory bowel disease, afflicts 1-2 million people in the United States, and many more worldwide. Although the exact cause of ulcerative colitis remains undetermined, the condition appears to be related to a combination of genetic and environmental factors. While conventional treatments can be effective in maintaining remission and decreasing the length of active disease periods, the treatments are not without side effects, and a significant number of people suffering from UC fail to respond to even the strongest drugs. This article reviews potential unconventional treatments – transdermal nicotine, heparin, melatonin, DHEA, probiotics, fiber, dietary changes, botanicals, essential fatty acids, and other nutrients – that may be considered in conjunction with conventional approaches or as part of a comprehensive alternative treatment protocol. In addition this review addresses risk factors, pathogenesis, nutrient deficiencies, conventional treatment approaches, and extra-intestinal manifeststations of the disease.


Cite this article:
Nikhil A. Zanke, Dr.Tushar Dhekane, Ananta B. Ghonge, Ashwini A. Zanke, Akshay Akotakar. A Review of Ulcerative Colitis. International Journal of Technology. 2022; 12(2):43-6. doi: 10.52711/2231-3915.2022.00008

Cite(Electronic):
Nikhil A. Zanke, Dr.Tushar Dhekane, Ananta B. Ghonge, Ashwini A. Zanke, Akshay Akotakar. A Review of Ulcerative Colitis. International Journal of Technology. 2022; 12(2):43-6. doi: 10.52711/2231-3915.2022.00008   Available on: https://ijtonline.com/AbstractView.aspx?PID=2022-12-2-5


REFERENCES:
1.    Hanauer SB. Inflammatory bowel disease. N Engl J Med 1996; 334(13): 841–8
2.    Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 1997; 92(2): 204–11.
3.    Cohen RD, Woseth DM, Thisted RA, Hanauer SB. A metaanalysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. Am J Gastroenterol 2000; 95(5): 1263–76
4.    Das KM, Dubin R. Clinical pharmacokinetics of sulphasalazine. Clin Pharmacokinetics 1976; 1: 406–25.
5.    Ragunath K, Williams JG. Review article: balsalazide therapy in ulcerative colitis. Aliment Pharmacol Ther 2001; 15(10): 1549–54.
6.    Crohn’s and Colitis Foundation of America, Inc. 1996-2002. http://www.ccfa.org/physician/colitisb.html
7.    MayoClinic.com, Mayo Foundation for Medical Education and Research (MFMER). 1998-2003. http://www.mayoclinic.com/ invoke.cfm?id=DS00104.
8.    University of California, Davis Medical Center. http://www.ucdmc.ucdavis.edu/ucdhs/ health/a-z/69UlcerativeColitis/doc69risks.html
9.    Corrao G, Tragnone A, Caprilli R, et al. Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC). Int J Epidemiol 1998; 27: 397-404.
10.    Rigas A, Rigas B, Glassman M, et al. Breastfeeding and maternal smoking in the etiology of Crohn’s disease and ulcerative colitis in childhood. Ann Epidemiol 1993; 3: 387-392
11.    Kurina LM, Goldacre MJ, Yeates D, Seatgroatt V. Appendicectomy, tonsillectomy, and inflammatory bowel disease: a case-control record linkage study. J Epidemiol Community Health 2002; 56: 551-554.
12.    Mitchell SA, Thyssen M, Orchard TR, et al. Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study. Gut 2002; 51: 567-573.
13.    Boyko EJ, Koepsell TD, Perera DR, Inui TS. Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med 1987; 316: 707-710
14.    Persson PG, Ahlbom A, Hellers G. Diet and inflammatory bowel disease: a case-control study. Epidemiology 1992; 3: 47-52
15.    Tragnone A, Valpiani D, Miglio F, et al. Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995; 7: 47-51.
16.    Morris DL, Montgomery SM, Galloway ML, et al. Inflammatory bowel disease and laterality: is left handedness a risk? Gut 2001; 49: 199-202.
17.    Persson PG, Ahlbom A. Relative risk is a relevant measure of association of lefthandedness with inflammatory bowel disease. Neuropsychologia 1988; 26: 737-740
18.    Kurina LM, Goldacre MJ, Yeates D, Gill LE. Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Community Health 2001; 55: 716-720.
19.    Tocchi A, Lepre L, Liotta G, et al. Familial and psychological risk factors of ulcerative colitis. Ital J Gastroenterol Hepatol 1997; 29: 395-398.
20.    Wahl C, Liptay S, Adler G, Schmid RM. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest 1998; 101: 1163-1174.
21.    Cipolla G, Crema F, Sacco S, et al. Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: current perspectives. Pharmacol Res 2002; 46: 1-6.
22.    Jani N, Regueiro MD. Medical therapy for ulcerative colitis. Gastroenterol Clin North Am 2002; 31: 147-166. Page 278 Alternative Medicine Review,Volume 8, Number 3, 2003 Ulcerative Colitis Review Copyright©2003 Thorne Research, Inc. All Rights Reserved. No Reprint Without Written Permission
23.    Pitcher MC, Beatty ER, Cummings JH. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut 2000; 46: 64-72.
24.    Roediger W, Schapel G, Lawson M, et al. Effect of 5-aminosalicylic acid (5-ASA) and other salicylates on short-chain fat metabolism in the colonic mucosa. Pharmacological implications for ulcerative colitis. Biochem Pharmacol 1986; 35: 221-225.

Recomonded Articles:

Author(s): P. L. Sharma, S. Kumar

DOI:         Access: Open Access Read More

Author(s): Nikhil A. Zanke, Dr.Tushar Dhekane, Ananta B. Ghonge, Ashwini A. Zanke, Akshay Akotakar

DOI: 10.52711/2231-3915.2022.00008         Access: Open Access Read More

International Journal of Technology (IJT) is an international, peer-reviewed journal, research journal aiming at promoting and publishing original high quality research in all disciplines of engineering sciences and technology...... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231-3915 


Recent Articles




Tags